39 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
on the packaging after considering Licensor’s request in good faith. [***]
5.5. Promotional Materials. Licensee is responsible for and has the sole … decision authority in creating, developing, producing, or otherwise obtaining and utilizing sales and marketing materials (including without limitation
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
materials and consumable supplies
Office expenses
Others
6.Employee Benefit Expenses
Six Months Ended June 30,
RMB’000
Wages, salaries and bonuses … and development activities, (4) expenses to develop our product candidates, including raw materials and supplies, product testing, manufacturing services
CORRESP
CNTB
Connect Biopharma Holdings Ltd
24 Jul 23
Correspondence with SEC
12:00am
with your required submission under paragraph (a). Please supplementally describe any additional materials that were reviewed and tell us whether you … a similarly detailed discussion of the materials reviewed and legal opinions or third-party certifications relied upon in connection with the required
UPLOAD
CNTB
Connect Biopharma Holdings Ltd
11 Jul 23
Letter from SEC
12:00am
describe any additional materials
that were reviewed
and tell us whether you relied upon any legal opinions or third-party
certifications … such as
affidavits as the basis for your submission. In your response, please
provide a similarly
detailed discussion of the materials
6-K
EX-99.1
vjzirf9h35ykwegss3ed
23 Jun 23
House Lease Contract
4:31pm
6-K
faxsg bjc
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
F-3/A
jhix5ciuw
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
6-K
tb5f2ygwn tzs
10 Jun 22
Current report (foreign)
6:05am
F-3/A
oqf2yjkj
20 May 22
Shelf registration (foreign) (amended)
6:54pm
F-3
0yrlagp uynu
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
EX-1.2
0usv7gw3603f
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
EX-2.5
d2daqwyiqz6ebbovz
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.12
6f0r uj10i
31 Mar 22
Annual report (foreign)
4:33pm
20-F
e0pq2xikvkcv9 01ado
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.13
h6kwilv5sv
31 Mar 22
Annual report (foreign)
4:33pm
6-K
n41b09tll62r 3c
16 Feb 22
Current report (foreign)
4:01pm
6-K
o3qdyk
22 Nov 21
Current report (foreign)
5:12pm
6-K
EX-99.1
5oac6sr
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm